Accessibility Statement Skip Navigation
  • Resources
  • Blog
  • Journalists
  • +44 (0)20 7454 5110
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All Public Company News
      • All Multimedia News
      • View All News Releases

      • Regulatory News

      • D/A/CH Regulatory News
      • UK Regulatory News
      • View All Regulatory News

  • Business & Money
      • Auto & Transportation

      • Aerospace & Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads & Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking & Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers & Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalisation
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls & Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil & Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defence
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation & Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking & Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers & Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines & Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics & Personal Care
      • Fashion
      • Food & Beverages
      • Furniture & Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewellery
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks & Tourist Attractions
      • Gambling & Casinos
      • Hotels & Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Animal Welfare
      • Corporate Social Responsibility
      • Economic News, Trends & Analysis
      • Education
      • Environmental
      • European Government
      • Labour & Union
      • Natural Disasters
      • Not For Profit
      • Public Safety
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Overview
  • Distribution
  • Paid Placement
  • Multimedia
  • Disclosure Services
  • SocialBoost
  • Rooms
    • MediaRoom
    • ESG Rooms
  • AI Tools
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Hamburger menu
  • Cision PR Newswire UK provides press release distribution, targeting, monitoring, and marketing services
  • Send a Release
    • Phone

    • +44 (0)20 7454 5110 from 8 AM - 5:30 PM GMT

    • ALL CONTACT INFO
    • Contact Us

      +44 (0)20 7454 5110
      from 8 AM - 5:30 PM GMT

  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • News in Focus
    • Browse News Releases
    • Regulatory News
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
    • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • Overview
  • Distribution
  • Paid Placement
  • Multimedia
  • Disclosure Services
  • Cision Communications Cloud®
  • AI Tools
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists

Kawasaki INnovation Gateway at SKYFRONT Research Highlights, 'Replicating Parkinson's Disease Brains in the Laboratory' and 'Mapping Brain Function of Monkey'


News provided by

KING SKYFRONT

12 Feb, 2019, 07:23 GMT

Share this article

Share toX

Share this article

Share toX

KAWASAKI CITY, Japan, Feb. 12, 2019 /PRNewswire/ -- Researchers affiliated with the Kawasaki INnovation Gateway at SKYFRONT report on "Replicating Parkinson's disease brains in the laboratory" and "Mapping brain function of monkey".

Continue Reading
This image opens in the lightbox
research_monkey
This image opens in the lightbox
research1

Further information about science and technology projects at Kawasaki City is available in the Kawasaki SkyFront iNewsletter that highlights research being conducted by scientists and industries affiliated with Kawasaki INnovation Gateway at SKYFRONT (KING SKYFRONT) — the City's flagship science and technology hub launched in 2013 to focus on open innovation in the life sciences and environment.

February 2019 issue of Kawasaki SkyFront iNewsletter

http://inewsletter-king-skyfront.jp/en/

Research highlights

http://inewsletter-king-skyfront.jp/en/research_highlights/

Replicating Parkinson's disease brains in the laboratory

Stem cell technology finds its application in elucidating Parkinson's disease using patient-derived cells

http://inewsletter-king-skyfront.jp/en/research_highlights/vol-14-research02/

Parkinson's disease (PD) is the second most common neurodegenerative disorder, implicating 10 million people worldwide but has no cure at present. The main reason for this is the difficulty scientists face with replicating damage seen in the parkinsonian brain, in the laboratory. Yoshikuni Tabata, Hideyuki Okano and their team at Keio University have developed a model to understand PD better, using induced pluripotent stem cell (iPSC) technology.

iPSCs are mature cells that can be manipulated to grow into specialized cells in the body, such as kidney, liver or brain cells (neurons). This technology has been exploited in regenerative therapy. Tabata and colleagues used iPSCs derived from PD patients with a specific gene mutation (called as PARK2). The iPSCs were manipulated by a process known as differentiation, into dopaminergic neurons; the subtype of neurons which are damaged in PD. Thus, the same neurons found damaged in the patient brain, were now present in the laboratory.

The primary toxic pathway involved in PD is oxidative stress; it leads to accumulation of toxic chemicals in the neurons which endogenous antioxidants can no longer combat. The differentiated PARK2 mutant neurons, indeed had high levels of oxidative stress. They were also susceptible to death induced by exposure to rotenone, an insecticide known to damage the mitochondria and cause PD. This suggested the role of the healthy (non-mutated) PARK2 gene in maintaining oxidative balance and protecting the mitochondria.

The research team then chose a panel of drugs with varying mechanisms, to assess their effects in PARK2 related PD. Candidates were shortlisted based on their ability to protect these neurons against rotenone-induced death. A type of calcium channel antagonist, showed great promise in this regard. Such compounds stabilize calcium levels in the cell, by blocking their influx through specific channels, known as T-type calcium channels. These effects were also confirmed in another PD specific mutation (PARK6) stem cell line, showing very similar properties to PARK2. The role of the T-type calcium channels in causing neuron death in PD, thus came to light.

This study provides a promising model for mimicking the damage occurring in parkinsonian brains. The authors conclude, "this model can be used to investigate the pathogenesis of the disease and search for potential therapeutic targets for PD". True advances can only be made once accurate depiction of any disease is achievable.

Reference:

Tabata, Y. et al. T-type Calcium Channels Determine the Vulnerability of Dopaminergic Neurons to Mitochondrial Stress in Familial Parkinson Disease. Stem Cell Reports 11, 1-14 (2018)

https://doi.org/10.1016/j.stemcr.2018.09.006

Mapping brain function of monkeys

A novel technology has made it easier to visualize patterns in the brains of naturally behaving non-human primates

http://inewsletter-king-skyfront.jp/en/research_highlights/vol-14-research01/

Non-human primates (NHP) have very similar social and cognitive processing to humans. Therefore, our knowledge of human behaviour can be advanced by studying the brains of NHPs. Takahiro Kondo, Hideyuki Okano and colleagues at Keio University have developed a new method of imaging neurons in the marmoset brain, a huge advancement in this field.

Traditional imaging studies on NHPs are done using head fixation, in an isolated setting. This renders it impossible to understand cognitive processes of NHPs in a natural setting. The team led by Kondo, developed a method of introducing a miniature lens into the marmoset brain, enabling them to visualize activity without the need for head fixation. For their research, the miniature lens was introduced into the motor cortex; the region responsible for planning and execution of voluntary motor movements.

After carefully mapping the motor cortex, a fluorescent calcium probe was introduced. When neurons are firing, there is influx and efflux of calcium, which can be captured with light emitted from these probes. The prism shaped lens was then fixed in after ensuring it could detect the light signal. Using their technique, up to 80-250 neurons could be captured at a time.

The device was then tested over several movement related tasks the marmosets underwent. It was observed that a subgroup of neurons was active during pulling and climbing movements, activities inherent to the animals. During periods of rest, another set of neurons showed positive calcium signals, as opposed to no activity in the motor cortex. To then study direction-based voluntary movement, the animals were presented with pellets (treats) periodically, located on either their right or left side. It was now seen that more subtypes of neurons were involved, each in the different phases of this task: before reaching for the pellet, during the actual reaching movement, and at the time of retrieval.

In their study, Kondo and co-workers highlighted the role of different neuron subtypes during naturalistic and directional voluntary movement. However, such advanced imaging will also aid in understanding neurological conditions affecting small regions of the brain, such as stroke. They positively conclude that, "This technology will make it possible to dissect large-scale neural circuits during human-relevant behaviour under natural conditions, enabling the study of complex behaviours, including social interaction, fear, and anxiety, and cognitive motor tasks".

Reference

Kondo, T. et al. Calcium Transient Dynamics of Neural Ensembles in the Primary Motor Cortex of Naturally Behaving Monkeys. Cell Reports 24, 2191-2195 (2018).

https://doi.org/10.1016/j.celrep.2018.07.057

http://www.city.kawasaki.jp/en/category/132-5-0-0-0-0-0-0-0-0.html

About KING SKYFRONT

KING SKYFRONT is located on the opposite side of the Tama River that separates Tokyo International Airport (also known as Haneda Airport) and the Tonomachi district of Kawasaki. The Airport plays an important role in the globalization of the innovative activities of scholars, industrialists and City administrators based at KING SKYFRONT.

KING SKYFRONT was launched in 2013 as a base for scholars, industrialists and government administrators to work together to devise real life solutions to global issues in the life sciences and environment.

Further information :
Coastal Area International Strategy Headquarters, Kawasaki City, Japan,
1 Miyamoto-cho, Kawasaki-ku, Kawasaki-city, Kanagawa 210-8577 Japan
email: 59jigyo@city.kawasaki.jp

Modal title

Contact PR Newswire

  • +44 (0)20 7454 5110
    from 8 AM - 5:30 PM GMT
  • General Enquiries
  • Media Enquiries
  • Partnerships

Products

  • Content Distribution
  • Multimedia Services
  • Disclosure Services
  • Cision Communications Cloud®

About

  • About PR Newswire
  • About Cision
  • Partnering Opportunities
  • Careers
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United States
  • Vietnam

My Services

  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
  • Data Privacy

Do not sell or share my personal information:

  • Submit via Privacy@cision.com 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
+44 (0)20 7454 5110
from 8 AM - 5:30 PM GMT
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 PR Newswire Europe Limited. All Rights Reserved. A Cision company.